Depression at NPA 32nd Annual Psychopharmacology Update 2027
6 sessions on depression · February 10–13, 2027, Las Vegas, NV. Compare depression at other meetings →
Wednesday, February 10
Lecture · Pre-Conference: Women's Mental Health Throughout the Lifespan
Women's Health and Cycle-Linked Mood Disorders
Evaluation and management of mood disorders linked to the menstrual cycle, including premenstrual exacerbations and PMDD.
Lecture · Pre-Conference: Women's Mental Health Throughout the Lifespan
The Menopause Transition: Mood and Anxiety
Mood and anxiety symptoms during perimenopause and menopause, with hormonal and psychopharmacologic treatment options.
Thursday, February 11
Lecture
Accelerated Neuromodulation in the Treatment of Depression
Accelerated TMS protocols and other rapid-acting neuromodulation strategies for depression.
Lecture
Treating Anxiety in Patients with Depression and Bipolar Disorder
Managing comorbid anxiety in mood disorders, where standard anxiolytic strategies can complicate treatment.
Friday, February 12
Lecture
Treatment of Mood Disorders in Children and Adolescents
Current approaches to treating depression and bipolar disorder in youth.
Lecture
What is the Role of Glutamate in Depression?
The glutamate hypothesis of depression and its therapeutic implications, from ketamine to emerging agents.
Other topics at this meeting
Perinatal & Women's Mental Health 8Anxiety Disorders 4Antipsychotic Prescribing 3Bipolar Disorder 3Child & Adolescent 3Dementia & Cognitive Disorders 3OCD & Related Disorders 3Substance Use Disorders 3ADHD 2Drug Interactions & Safety 2Measurement-Based Care & Diagnosis 2Psychotherapy 2